Zenas BioPharma to present obexelimab data at IGG4ward symposium
Zenas BioPharma said it will present upcoming obexelimab data in IGG4-related disease at the IGG4ward! 6th International Symposium on IGG4-related Disease and ACR Convergence 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.